-transparent.png){kind=logo}
Pyracetam was found to inhibit free-radical lipid peroxidation, slow oxygen consumption in the liver mitochondria and increase hemoglobin oxygen-binding properties. It is assumed that the ability of pyracetam to inhibit lipid peroxidation is a mechanism which determines its antihypoxic effect.
Related Publications
V M Gukasov, and
M M Rasulov, and
S N Efuni, and
E Ia Kaplan, and
V I Smiriagina
January 1989,
Biomedica biochimica acta,
V M Gukasov, and
M M Rasulov, and
S N Efuni, and
E Ia Kaplan, and
V I Smiriagina
January 1977,
Farmakologiia i toksikologiia,
V M Gukasov, and
M M Rasulov, and
S N Efuni, and
E Ia Kaplan, and
V I Smiriagina
January 2012,
Eksperimental'naia i klinicheskaia farmakologiia,
V M Gukasov, and
M M Rasulov, and
S N Efuni, and
E Ia Kaplan, and
V I Smiriagina
April 1983,
Die Pharmazie,
V M Gukasov, and
M M Rasulov, and
S N Efuni, and
E Ia Kaplan, and
V I Smiriagina
January 1992,
Eksperimental'naia i klinicheskaia farmakologiia,
V M Gukasov, and
M M Rasulov, and
S N Efuni, and
E Ia Kaplan, and
V I Smiriagina
January 1991,
Farmakologiia i toksikologiia,
V M Gukasov, and
M M Rasulov, and
S N Efuni, and
E Ia Kaplan, and
V I Smiriagina
January 1994,
Fiziologiia cheloveka,
V M Gukasov, and
M M Rasulov, and
S N Efuni, and
E Ia Kaplan, and
V I Smiriagina
January 1981,
Sovetskaia meditsina,
V M Gukasov, and
M M Rasulov, and
S N Efuni, and
E Ia Kaplan, and
V I Smiriagina
January 1981,
Eksperimentalna meditsina i morfologiia,
V M Gukasov, and
M M Rasulov, and
S N Efuni, and
E Ia Kaplan, and
V I Smiriagina
January 1990,
Farmakologiia i toksikologiia,
